These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35814521)

  • 1. Quantitative Ultrasound Assessment of Hepatic Steatosis.
    Kaliaev A; Chavez W; Soto J; Huda F; Xie H; Nguyen M; Shamdasani V; Anderson S
    J Clin Exp Hepatol; 2022; 12(4):1091-1101. PubMed ID: 35814521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.
    Pirmoazen AM; Khurana A; Loening AM; Liang T; Shamdasani V; Xie H; El Kaffas A; Kamaya A
    Invest Radiol; 2022 Jan; 57(1):23-32. PubMed ID: 34049335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Fat Quantification by Ultrasound in Children: A Prospective Study.
    D'Hondt A; Rubesova E; Xie H; Shamdasani V; Barth RA
    AJR Am J Roentgenol; 2021 Oct; 217(4):996-1006. PubMed ID: 33438457
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.
    Frankland MP; Dillman JR; Anton CG; Coley BD; Nasser MP; O'Hara SM; Li Y; Trout AT
    Pediatr Radiol; 2022 Jun; 52(7):1306-1313. PubMed ID: 35229183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
    Jeon SK; Lee JM; Joo I; Park SJ
    Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography.
    Rodge GA; Goenka MK; Goenka U; Afzalpurkar S; Shah BB
    J Clin Exp Hepatol; 2021; 11(5):586-591. PubMed ID: 34511820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
    Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
    PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.
    Gatos I; Drazinos P; Yarmenitis S; Theotokas I; Koskinas J; Koullias E; Mitranou A; Manesis E; Zoumpoulis PS
    Ultrasound Q; 2022 Jun; 38(2):124-132. PubMed ID: 35353797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound Shear Wave Attenuation Imaging for Grading Liver Steatosis in Volunteers and Patients With Non-alcoholic Fatty Liver Disease: A Pilot Study.
    Yazdani L; Rafati I; Gesnik M; Nicolet F; Chayer B; Gilbert G; Volniansky A; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Tang A; Cloutier G
    Ultrasound Med Biol; 2023 Oct; 49(10):2264-2272. PubMed ID: 37482477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.
    Jeon SK; Lee JM; Joo I; Yoon JH; Lee G
    Radiology; 2023 Apr; 307(1):e221510. PubMed ID: 36594835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease.
    Kaposi PN; Zsombor Z; Rónaszéki AD; Budai BK; Csongrády B; Stollmayer R; Kalina I; Győri G; Bérczi V; Werling K; Maurovich-Horvat P; Folhoffer A; Hagymási K
    Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease.
    Zsombor Z; Rónaszéki AD; Csongrády B; Stollmayer R; Budai BK; Folhoffer A; Kalina I; Győri G; Bérczi V; Maurovich-Horvat P; Hagymási K; Kaposi PN
    Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984470
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
    Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
    J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.
    Paige JS; Bernstein GS; Heba E; Costa EAC; Fereirra M; Wolfson T; Gamst AC; Valasek MA; Lin GY; Han A; Erdman JW; O'Brien WD; Andre MP; Loomba R; Sirlin CB
    AJR Am J Roentgenol; 2017 May; 208(5):W168-W177. PubMed ID: 28267360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
    Caussy C; Brissot J; Singh S; Bassirian S; Hernandez C; Bettencourt R; Rizo E; Richards L; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1842-1850.e6. PubMed ID: 31843596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
    Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tofogliflozin and pioglitazone on hepatic steatosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A randomized, open-label pilot study (ToPiND study).
    Ozaki A; Yoneda M; Kessoku T; Iwaki M; Kobayashi T; Honda Y; Ogawa Y; Imajo K; Sakai E; Taguri M; Yamanaka T; Iwasaki T; Kurihashi T; Saito S; Nakajima A
    Contemp Clin Trials Commun; 2020 Mar; 17():100516. PubMed ID: 31956725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.